Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation

Rheum Dis Clin North Am. 2010 May;36(2):213-41. doi: 10.1016/j.rdc.2010.02.001.


Rheumatoid arthritis (RA) likely develops in several phases, beginning with genetic risk, followed by asymptomatic autoimmunity, then finally, clinically apparent disease. Investigating the phases of disease that exist prior to the onset of symptoms (ie, the preclinical period of RA) will lead to understanding of the important relationships between genetic and environmental factors that may lead to disease, as well as allow for the development of predictive models for disease, and ultimately preventive strategies for RA.

Publication types

  • Review

MeSH terms

  • Animals
  • Arthritis, Rheumatoid* / epidemiology
  • Arthritis, Rheumatoid* / genetics
  • Arthritis, Rheumatoid* / immunology
  • Autoantibodies / immunology
  • Autoimmunity / genetics*
  • Autoimmunity / immunology*
  • Disease Models, Animal
  • Humans
  • Peptides, Cyclic / immunology
  • Rheumatology / trends*
  • Risk Factors


  • Autoantibodies
  • Peptides, Cyclic
  • cyclic citrullinated peptide